Revenue
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $418.0M | $571.0M | $704.2M | $759.2M | $758.2M | $820.5M | $910.9M |
| Research & development | $11.6M | $11.6M | — | — | — | — | — |
| Operating expenses | $211.8M | $207.8M | $204.6M | $259.0M | $236.9M | $181.6M | $165.5M |
| Operating income | −$303.9M | −$40.3M | $568.8M | $296.5M | $409.1M | $404.5M | $478.3M |
| EBITDAderived | −$165.3M | — | — | — | — | — | — |
| Net income | −$155.4M | −$87.7M | $157.1M | −$23.8M | $92.5M | $244.8M | $187.2M |
| Basic EPSper diluted share | -CA$10.61 | -CA$6.29 | CA$11.71 | -CA$1.93 | CA$2.05 | CA$4.95 | CA$3.78 |
| Diluted EPSper diluted share | -CA$10.61 | -CA$6.29 | CA$11.29 | -CA$1.93 | CA$1.99 | CA$4.92 | CA$3.76 |